These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 26690378)
21. Added benefit of raxibacumab to antibiotic treatment of inhalational anthrax. Migone TS; Bolmer S; Zhong J; Corey A; Vasconcelos D; Buccellato M; Meister G Antimicrob Agents Chemother; 2015 Feb; 59(2):1145-51. PubMed ID: 25487792 [TBL] [Abstract][Full Text] [Related]
22. Analysis of Anthrax Immune Globulin Intravenous with Antimicrobial Treatment in Injection Drug Users, Scotland, 2009-2010. Cui X; Nolen LD; Sun J; Booth M; Donaldson L; Quinn CP; Boyer AE; Hendricks K; Shadomy S; Bothma P; Judd O; McConnell P; Bower WA; Eichacker PQ Emerg Infect Dis; 2017 Jan; 23(1):56-65. PubMed ID: 27983504 [TBL] [Abstract][Full Text] [Related]
23. Animal-to-Human Dose Translation of Obiltoxaximab for Treatment of Inhalational Anthrax Under the US FDA Animal Rule. Nagy CF; Mondick J; Serbina N; Casey LS; Carpenter SE; French J; Guttendorf R Clin Transl Sci; 2017 Jan; 10(1):12-19. PubMed ID: 27925405 [TBL] [Abstract][Full Text] [Related]
24. Raxibacumab for the treatment of inhalational anthrax. Migone TS; Subramanian GM; Zhong J; Healey LM; Corey A; Devalaraja M; Lo L; Ullrich S; Zimmerman J; Chen A; Lewis M; Meister G; Gillum K; Sanford D; Mott J; Bolmer SD N Engl J Med; 2009 Jul; 361(2):135-44. PubMed ID: 19587338 [TBL] [Abstract][Full Text] [Related]
25. Combination therapy with antibiotics and anthrax immune globulin intravenous (AIGIV) is potentially more effective than antibiotics alone in rabbit model of inhalational anthrax. Kammanadiminti S; Patnaikuni RK; Comer J; Meister G; Sinclair C; Kodihalli S PLoS One; 2014; 9(9):e106393. PubMed ID: 25226075 [TBL] [Abstract][Full Text] [Related]
26. Human monoclonal antibodies against anthrax lethal factor and protective antigen act independently to protect against Bacillus anthracis infection and enhance endogenous immunity to anthrax. Albrecht MT; Li H; Williamson ED; LeButt CS; Flick-Smith HC; Quinn CP; Westra H; Galloway D; Mateczun A; Goldman S; Groen H; Baillie LW Infect Immun; 2007 Nov; 75(11):5425-33. PubMed ID: 17646360 [TBL] [Abstract][Full Text] [Related]
27. Special considerations for prophylaxis for and treatment of anthrax in pregnant and postpartum women. Meaney-Delman D; Zotti ME; Creanga AA; Misegades LK; Wako E; Treadwell TA; Messonnier NE; Jamieson DJ; Emerg Infect Dis; 2014 Feb; 20(2):. PubMed ID: 24457117 [TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of AVP-21D9, an anthrax monoclonal antibody, in animal models and humans. Malkevich NV; Hopkins RJ; Bernton E; Meister GT; Vela EM; Atiee G; Johnson V; Nabors GS; Aimes RT; Ionin B; Skiadopoulos MH Antimicrob Agents Chemother; 2014 Jul; 58(7):3618-25. PubMed ID: 24733473 [TBL] [Abstract][Full Text] [Related]
29. A systematic review and meta-analysis of preclinical trials testing anti-toxin therapies for B. anthracis infection: A need for more robust study designs and results. Xu W; Ohanjanian L; Sun J; Cui X; Suffredini D; Li Y; Welsh J; Eichacker PQ PLoS One; 2017; 12(8):e0182879. PubMed ID: 28797061 [TBL] [Abstract][Full Text] [Related]
30. Evaluation of Combination Drug Therapy for Treatment of Antibiotic-Resistant Inhalation Anthrax in a Murine Model. Heine HS; Shadomy SV; Boyer AE; Chuvala L; Riggins R; Kesterson A; Myrick J; Craig J; Candela MG; Barr JR; Hendricks K; Bower WA; Walke H; Drusano GL Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28696235 [No Abstract] [Full Text] [Related]
31. Revisiting the Concept of Targeting Only Bacillus anthracis Toxins as a Treatment for Anthrax. Glinert I; Bar-David E; Sittner A; Weiss S; Schlomovitz J; Ben-Shmuel A; Mechaly A; Altboum Z; Kobiler D; Levy H Antimicrob Agents Chemother; 2016 Aug; 60(8):4878-85. PubMed ID: 27270276 [TBL] [Abstract][Full Text] [Related]
32. A high-affinity monoclonal antibody to anthrax protective antigen passively protects rabbits before and after aerosolized Bacillus anthracis spore challenge. Mohamed N; Clagett M; Li J; Jones S; Pincus S; D'Alia G; Nardone L; Babin M; Spitalny G; Casey L Infect Immun; 2005 Feb; 73(2):795-802. PubMed ID: 15664918 [TBL] [Abstract][Full Text] [Related]
33. Identifying Meningitis During an Anthrax Mass Casualty Incident: Systematic Review of Systemic Anthrax Since 1880. Katharios-Lanwermeyer S; Holty JE; Person M; Sejvar J; Haberling D; Tubbs H; Meaney-Delman D; Pillai SK; Hupert N; Bower WA; Hendricks K Clin Infect Dis; 2016 Jun; 62(12):1537-1545. PubMed ID: 27025833 [TBL] [Abstract][Full Text] [Related]
34. CDC updates interim guidelines for anthrax exposure management and antimicrobial therapy. Ressel G; Am Fam Physician; 2001 Dec; 64(11):1901-2, 1904. PubMed ID: 11764868 [No Abstract] [Full Text] [Related]
35. High-sensitivity MALDI-TOF MS quantification of anthrax lethal toxin for diagnostics and evaluation of medical countermeasures. Boyer AE; Gallegos-Candela M; Quinn CP; Woolfitt AR; Brumlow JO; Isbell K; Hoffmaster AR; Lins RC; Barr JR Anal Bioanal Chem; 2015 Apr; 407(10):2847-58. PubMed ID: 25673244 [TBL] [Abstract][Full Text] [Related]
36. Efficacy of Single and Combined Antibiotic Treatments of Anthrax in Rabbits. Weiss S; Altboum Z; Glinert I; Schlomovitz J; Sittner A; Bar-David E; Kobiler D; Levy H Antimicrob Agents Chemother; 2015 Dec; 59(12):7497-503. PubMed ID: 26392505 [TBL] [Abstract][Full Text] [Related]
37. Guidelines for treatment of anthrax. Meyerhoff A; Murphy D JAMA; 2002 Oct; 288(15):1848-9; author reply 1848-9. PubMed ID: 12377082 [No Abstract] [Full Text] [Related]